Skip Nav Destination
Modern Trends in Psychiatry
Monoamine Oxidase and Its Selective Inhibitors: Satellite Symposium, International Brain Research Organization (IBRO), Mannheim, March 1982Available to Purchase
Edited by
S.Karger AG
Volume
19
Status:
Available
ISBN electronic:
978-3-318-03974-0
ISBN print:
978-3-8055-3595-3
Subject Area:
Further Areas
,
Neurology and Neuroscience
,
Pathology and Cell Biology
,
Pharmacology
,
Psychiatry and Psychology
Book Series:
Modern Trends in Psychiatry
Published online:
2015
Published in print:
1983
Monoamine Oxidase and Its Selective Inhibitors: Satellite Symposium, International Brain Research Organization (IBRO), Mannheim, March 1982
Edited by: H. Beckmann, P. Riederer
https://doi.org/10.1159/isbn.978-3-318-03974-0
ISBN (print): 978-3-8055-3595-3
ISBN (electronic): 978-3-318-03974-0
Publisher: S.Karger AG
Published: 1983
Download citation file:
Digital Version
Pay-Per-View Access
$233.00
Print Version
Monoamine Oxidase and Its Selective Inhibitors
$233.00
Table of Contents
-
1 - 14: Monoamine Oxidase: Synthesis, Metabolism and FunctionByT. L. SourkesT. L. SourkesDepartments of Psychiatry and Biochemistry, Faculty of Medicine, McGill University, Montreal, Que., CanadaSearch for other works by this author on:
-
15 - 30: Factors Involved in the Selective Inhibition of Monoamine Oxidase1ByKeith F. Tipton;Keith F. TiptonDepartment of Biochemistry, Trinity College, Dublin, IrelandSearch for other works by this author on:Anne-Marie O’Carroll;Anne-Marie O’CarrollDepartment of Biochemistry, Trinity College, Dublin, IrelandSearch for other works by this author on:Timothy J. Mantle;Timothy J. MantleDepartment of Biochemistry, Trinity College, Dublin, IrelandSearch for other works by this author on:Christopher J. FowlerChristopher J. FowlerDepartment of Biochemistry, Trinity College, Dublin, IrelandSearch for other works by this author on:
-
31 - 52: Characterization of a New, Short-Acting and Specific Inhibitor of Type A Monoamine OxidaseByP. C. Waldmeier;P. C. WaldmeierDepartement Forschung, Division Pharma Ciba-Geigy AG, Basel, SchweizSearch for other works by this author on:P. A. Baumann;P. A. BaumannDepartement Forschung, Division Pharma Ciba-Geigy AG, Basel, SchweizSearch for other works by this author on:A. Delini-Stula;A. Delini-StulaDepartement Forschung, Division Pharma Ciba-Geigy AG, Basel, SchweizSearch for other works by this author on:R. Bernasconi;R. BernasconiDepartement Forschung, Division Pharma Ciba-Geigy AG, Basel, SchweizSearch for other works by this author on:K. Sigg;K. SiggDepartement Forschung, Division Pharma Ciba-Geigy AG, Basel, SchweizSearch for other works by this author on:O. Buech;O. BuechDepartement Forschung, Division Pharma Ciba-Geigy AG, Basel, SchweizSearch for other works by this author on:A. E. FelnerA. E. FelnerDepartement Forschung, Division Pharma Ciba-Geigy AG, Basel, SchweizSearch for other works by this author on:
-
53 - 62: Monoamine Oxidase Inhibition in Healthy Volunteers by CGP 11305 A, a New Specific Inhibitor of MAO-AByP. Bieck;P. BieckHuman Pharmacology Institute Ciba-Geigy, Tübingen, FRGSearch for other works by this author on:K. H. Antonin;K. H. AntoninHuman Pharmacology Institute Ciba-Geigy, Tübingen, FRGSearch for other works by this author on:Maria JedrychowskiMaria JedrychowskiHuman Pharmacology Institute Ciba-Geigy, Tübingen, FRGSearch for other works by this author on:
-
63 - 74: Implications of MAO-A and MAO-B Inhibition for Antidepressant TherapyByM. B. H. Youdim;M. B. H. YoudimDepartment of Pharmacology, Faculty of Medicine, Technion, Haifa, IsraelSearch for other works by this author on:J. P. M. FinbergJ. P. M. FinbergDepartment of Pharmacology, Faculty of Medicine, Technion, Haifa, IsraelSearch for other works by this author on:
-
75 - 81: A New Assay of Monoamine Oxidase Activity for Selective Substrates and InhibitorsByS. Kawai;S. KawaiaGifu College of Pharmacy, Gifu, Japan, andSearch for other works by this author on:T. Nakano;T. NakanobTokyo Institute of Technology, Yokohama, JapanSearch for other works by this author on:T. NagatsuT. NagatsubTokyo Institute of Technology, Yokohama, JapanSearch for other works by this author on:
-
82 - 104: Partial or Total Protection from Long-Acting Monoamine Oxidase Inhibitors (MAOIs) by New Short-Acting MAOIs of Type A MD780515 and Type B MD780236ByMargherita Strolin Benedetti;Margherita Strolin BenedettiaCentre de Recherche Delalande, Rueil-Malmaison, France;Search for other works by this author on:Philippe Dostert;Philippe DostertaCentre de Recherche Delalande, Rueil-Malmaison, France;Search for other works by this author on:Christian Guffroy;Christian GuffroyaCentre de Recherche Delalande, Rueil-Malmaison, France;Search for other works by this author on:Keith F. TiptonKeith F. TiptonbDepartment of Biochemistry, Trinity College, Dublin, IrelandSearch for other works by this author on:
-
105 - 117: Effect of Lipid Depletion and Solubilization on Inhibitor Sensitivity of Mitochondrial Monoamine Oxidase1ByH. Kinemuchi;H. KinemuchiDepartment of Pharmacology, School of Medicine, Showa University, Tokyo, JapanSearch for other works by this author on:Y. Sunami;Y. SunamiDepartment of Pharmacology, School of Medicine, Showa University, Tokyo, JapanSearch for other works by this author on:M. Yoshino;M. YoshinoDepartment of Pharmacology, School of Medicine, Showa University, Tokyo, JapanSearch for other works by this author on:K. Watanabe;K. WatanabeDepartment of Pharmacology, School of Medicine, Showa University, Tokyo, JapanSearch for other works by this author on:M. Sudo;M. SudoDepartment of Pharmacology, School of Medicine, Showa University, Tokyo, JapanSearch for other works by this author on:K. KamijoK. KamijoDepartment of Pharmacology, School of Medicine, Showa University, Tokyo, JapanSearch for other works by this author on:
-
118 - 125: Endogenous Urinary Monoamine Oxidase Inhibitor: The Benzodiazepine ConnectionByVivette Glover;Vivette GloverBernhard Baron Memorial Research Laboratories and Institute of Obstetrics and Gynaecology, Queen Charlotte’s Hospital, London, EnglandSearch for other works by this author on:Ines Armando;Ines ArmandoBernhard Baron Memorial Research Laboratories and Institute of Obstetrics and Gynaecology, Queen Charlotte’s Hospital, London, EnglandSearch for other works by this author on:Angela Clow;Angela ClowBernhard Baron Memorial Research Laboratories and Institute of Obstetrics and Gynaecology, Queen Charlotte’s Hospital, London, EnglandSearch for other works by this author on:Merton SandlerMerton SandlerBernhard Baron Memorial Research Laboratories and Institute of Obstetrics and Gynaecology, Queen Charlotte’s Hospital, London, EnglandSearch for other works by this author on:
-
126 - 134: Kinetics of MAO InhibitorsByE. Mutschler;E. MutschlerInstitute of Pharmacology for Basic Scientists of the Johann Wolfgang Goethe University, Frankfurt a.M., FRGSearch for other works by this author on:W. MöhrkeW. MöhrkeInstitute of Pharmacology for Basic Scientists of the Johann Wolfgang Goethe University, Frankfurt a.M., FRGSearch for other works by this author on:
-
135 - 153: Long-Lasting, True Aphrodisiac Effect of (−)-Deprenyl in Sexually Sluggish Old Male RatsByJ. Knoll;J. KnollDepartment of Pharmacology, Semmelweis University of Medicine, Budapest, HungarySearch for other works by this author on:T. T. Yen;T. T. YenDepartment of Pharmacology, Semmelweis University of Medicine, Budapest, HungarySearch for other works by this author on:J. DalloJ. DalloDepartment of Pharmacology, Semmelweis University of Medicine, Budapest, HungarySearch for other works by this author on:
-
154 - 161: Tranylcypromine Isomers in Parkinson’s Disease: Effect of Low Doses on Monoamine Oxidase Inhibition and Blood Pressure ResponseByP. Riederer;P. RiedererLudwig Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, and Department of Neurology, Lainz Geriatric Hospital, Vienna, AustriaSearch for other works by this author on:G. P. Reynolds;G. P. ReynoldsLudwig Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, and Department of Neurology, Lainz Geriatric Hospital, Vienna, AustriaSearch for other works by this author on:K. Jellinger;K. JellingerLudwig Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, and Department of Neurology, Lainz Geriatric Hospital, Vienna, AustriaSearch for other works by this author on:D. Seemann;D. SeemannLudwig Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, and Department of Neurology, Lainz Geriatric Hospital, Vienna, AustriaSearch for other works by this author on:W. DanielczykW. DanielczykLudwig Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, and Department of Neurology, Lainz Geriatric Hospital, Vienna, AustriaSearch for other works by this author on:
-
162 - 169: MAO Inhibitors in Psychiatric Therapy: Effects and Side EffectsByF. Rigal;F. RigalDepartment of Psychiatry (Pr Zarifian), C.H.U. St-Jacques Clermont-Ferrand, FranceSearch for other works by this author on:E. ZarifianE. ZarifianDepartment of Psychiatry (Pr Zarifian), C.H.U. St-Jacques Clermont-Ferrand, FranceSearch for other works by this author on:
-
170 - 176: (−)-Deprenyl Leads to Prolongation of L-Dopa Efficacy in Parkinson’s DiseaseByW. Birkmayer;W. BirkmayeraEvangelical Hospital, Vienna, Austria;Search for other works by this author on:J. Knoll;J. KnollbDepartment of Pharmacology, Semmelweis University, Budapest, Hungary;Search for other works by this author on:P. Riederer;P. RiederercL. Boltzmann Institute for Clinical Neurobiology, Neurochemistry Group, Vienna, Austria;Search for other works by this author on:M. B. H. YoudimM. B. H. YoudimdDepartment of Pharmacology, Technion, Haifa, IsraelSearch for other works by this author on:
-
177 - 188: Studies of the Type A and Type B Monoamine Oxidase: A New Approach to Their Development and Subcellular Localization1ByP. H. Yu;P. H. YuPsychiatric Research Division, University Hospital, and Department of Pharmacology, University of Saskatchewan, Saskatoon, Saskatchewan, CanadaSearch for other works by this author on:L. HertzL. HertzPsychiatric Research Division, University Hospital, and Department of Pharmacology, University of Saskatchewan, Saskatoon, Saskatchewan, CanadaSearch for other works by this author on:
-
189 - 202: Tranylcypromine Isomers in Depressed Outpatients: Effects on Depression, Monoamine Oxidase Inhibition and Tyramine Pressor ResponseByTheunis J. Van de Merwe;Theunis J. Van de MerweaDepartment of Psychological Medicine, St. Bartholomew’s Hospital, andSearch for other works by this author on:C. M. B. Pare;C. M. B. PareaDepartment of Psychological Medicine, St. Bartholomew’s Hospital, andSearch for other works by this author on:V. Glover;V. GloverbBernhard Baron Memorial Research Laboratories and Institute of Obstetrics and Gynaecology, Queen Charlotte’s Maternity Hospital, London, EnglandSearch for other works by this author on:M. SandlerM. SandlerbBernhard Baron Memorial Research Laboratories and Institute of Obstetrics and Gynaecology, Queen Charlotte’s Maternity Hospital, London, EnglandSearch for other works by this author on:
-
203 - 210: Effect of Tranylcypromine Stereoisomers on Depressive SyndromesByE. Rüther;E. RütherPsychiatric Hospital of the University of Munich, FRGSearch for other works by this author on:G. Jungkunz;G. JungkunzPsychiatric Hospital of the University of Munich, FRGSearch for other works by this author on:W. Greil;W. GreilPsychiatric Hospital of the University of Munich, FRGSearch for other works by this author on:R. ZimmerR. ZimmerPsychiatric Hospital of the University of Munich, FRGSearch for other works by this author on:
-
211 - 214: MAO Inhibition as Antidepressive Mechanism Reevaluated: A Controlled Study with Tranylcypromine IsomersByH. Beckmann;H. BeckmannPsychiatric Clinic of the Central Institute of Mental Health, Mannheim, FRGSearch for other works by this author on:H. W. MoisesH. W. MoisesPsychiatric Clinic of the Central Institute of Mental Health, Mannheim, FRGSearch for other works by this author on:
-
215 - 219: Clinical and Pharmacological Aspects of (−)-Deprenyl Treatment in Parkinson’s DiseaseByG. M. Stern;G. M. SternaDepartment of Neurology, University College Hospital, London;Search for other works by this author on:A. J. Lees;A. J. LeesaDepartment of Neurology, University College Hospital, London;Search for other works by this author on:R. Hardie;R. HardieaDepartment of Neurology, University College Hospital, London;Search for other works by this author on:M. SandlerM. SandlerbBernhard Baron Memorial Research Laboratories, Queen Charlotte’s Hospital, London, EnglandSearch for other works by this author on:
-
220 - 230: Cardiovascular Effects of (+)- and (−)-Tranylcypromine Compared to Other Monoamine Oxidase InhibitorsByK. Greeff;K. GreeffInstitute of Pharmacology, University of Düsseldorf, FRGSearch for other works by this author on:B. Dènes;B. DènesInstitute of Pharmacology, University of Düsseldorf, FRGSearch for other works by this author on:H. TawfikH. TawfikInstitute of Pharmacology, University of Düsseldorf, FRGSearch for other works by this author on:
-
231 - 245: Neurochemical Effects in vitro and in vivo of the Antidepressant Ro 11-1163, a Specific and Short-Acting MAO-A InhibitorByM. Da Prada;M. Da PradaPharmaceutical Research Department, F. Hoffmann-La Roche & Co., Ltd., Basle, SwitzerlandSearch for other works by this author on:R. Kettler;R. KettlerPharmaceutical Research Department, F. Hoffmann-La Roche & Co., Ltd., Basle, SwitzerlandSearch for other works by this author on:H. H. Keller;H. H. KellerPharmaceutical Research Department, F. Hoffmann-La Roche & Co., Ltd., Basle, SwitzerlandSearch for other works by this author on:W. E. HaefelyW. E. HaefelyPharmaceutical Research Department, F. Hoffmann-La Roche & Co., Ltd., Basle, SwitzerlandSearch for other works by this author on:
-
246 - 254: Monoamine Oxidase Activity and Localisation in the Brain and the Activity in Relation to Psychiatric Disorders1ByL. Oreland;L. OrelandaDepartment of Pharmacology, University of Umeå, Sweden;Search for other works by this author on:Y. Arai;Y. AraiaDepartment of Pharmacology, University of Umeå, Sweden;Search for other works by this author on:A. Stenström;A. StenströmaDepartment of Pharmacology, University of Umeå, Sweden;Search for other works by this author on:C. J. FowlerC. J. FowlerbAstra Drug Co., Södertälje, SwedenSearch for other works by this author on:
-
255 - 259: Assessment of MAO Inhibitors Using Postmortem Human Brain Tissue: Biochemical and Therapeutic ImplicationsByG. P. Reynolds;G. P. ReynoldsaMRC Neurochemical Pharmacology Unit, Medical School, Cambridge, England andSearch for other works by this author on:P. RiedererP. RiedererbNeurochemistry Group, Ludwig Boltzmann Institute for Clinical Neurobiology, Lainz Hospital, Vienna, AustriaSearch for other works by this author on:
-
260 - 264: Platelet Monoamine Oxidase Activity in Alcoholics1ByD. P. Agarwal;D. P. AgarwalaInstitute of Human Genetics, University of Hamburg, FRG;Search for other works by this author on:G. Philippu;G. PhilippubUniversitäts-Nervenklinik, Würzburg, FRGSearch for other works by this author on:U. Milech;U. MilechbUniversitäts-Nervenklinik, Würzburg, FRGSearch for other works by this author on:H. W. Goedde;H. W. GoeddeaInstitute of Human Genetics, University of Hamburg, FRG;Search for other works by this author on:O. SchrappeO. SchrappebUniversitäts-Nervenklinik, Würzburg, FRGSearch for other works by this author on:
-
265 - 277: Methodological Problems of Using Platelet MAO in Psychiatric ResearchByL. Demisch;L. DemischClinical Biochemistry Laboratory, Department of Psychiatry, Hospital of the University, Frankfurt FRGSearch for other works by this author on:P. Kaczmarczyk;P. KaczmarczykClinical Biochemistry Laboratory, Department of Psychiatry, Hospital of the University, Frankfurt FRGSearch for other works by this author on:P. GebhartP. GebhartClinical Biochemistry Laboratory, Department of Psychiatry, Hospital of the University, Frankfurt FRGSearch for other works by this author on:
-
278 - 286: Biological High-Risk Paradigm and Platelet MAO Activity in Community SamplesByM. S. Buchsbaum;M. S. BuchsbaumSection on Clinical Psychophysiology, National Institute of Mental Health, Bethesda, Md., USA; Department of Psychology, University of Maryland, College Park, Md., USASearch for other works by this author on:R. D. CourseyR. D. CourseySection on Clinical Psychophysiology, National Institute of Mental Health, Bethesda, Md., USA; Department of Psychology, University of Maryland, College Park, Md., USASearch for other works by this author on:
-
287 - 303: Clinical and Laboratory Studies with Selective Monoamine-Oxidase-Inhibiting Drugs: Implications for Hypothesized Neurotransmitter Changes Associated with Depression and Antidepressant Drug EffectsByD. L. Murphy;D. L. MurphyNational Institute of Mental Health, Bethesda, Md., USASearch for other works by this author on:R. M. Cohen;R. M. CohenNational Institute of Mental Health, Bethesda, Md., USASearch for other works by this author on:L. J. Siever;L. J. SieverNational Institute of Mental Health, Bethesda, Md., USASearch for other works by this author on:B. Roy;B. RoyNational Institute of Mental Health, Bethesda, Md., USASearch for other works by this author on:F. Karoum;F. KaroumNational Institute of Mental Health, Bethesda, Md., USASearch for other works by this author on:R. J. Wyatt;R. J. WyattNational Institute of Mental Health, Bethesda, Md., USASearch for other works by this author on:N. A. Garrick;N. A. GarrickNational Institute of Mental Health, Bethesda, Md., USASearch for other works by this author on:M. LinnoilaM. LinnoilaNational Institute of Mental Health, Bethesda, Md., USASearch for other works by this author on:
-
304 - 314: Platelet MAO Activity and High Risk for Psychopathology in a German Population1ByPeter Propping;Peter ProppingInstitut für Anthropologie und Humangenetik, Universität Heidelberg, Heidelberg, FRGSearch for other works by this author on:Waltraut FriedlWaltraut FriedlInstitut für Anthropologie und Humangenetik, Universität Heidelberg, Heidelberg, FRGSearch for other works by this author on:
-
315 - 320: Platelet MAO Activity in Major PsychosesByWagner F. GattazWagner F. GattazCentral Institute of Mental Health, Mannheim, FRGSearch for other works by this author on:
-
321 - 326: Changes in MAO Activity during Estrogen Treatment of Females with Endogenous DepressionByF. Holsboer;F. HolsboeraDepartment of Psychiatry, University of Mainz, andSearch for other works by this author on:O. Benkert;O. BenkertaDepartment of Psychiatry, University of Mainz, andSearch for other works by this author on:L. DemischL. DemischbDepartment of Psychiatry, University of Frankfurt, FRGSearch for other works by this author on:
-
327 - 336: Monoamine Oxidase Activity in Platelets before and after Sleep Deprivation as Predictor for Antidepressive Drug ResponseByE. Fähndrich;E. FähndrichDepartment of Psychiatry, Free University of BerlinSearch for other works by this author on:B. Müller-OerlinghausenB. Müller-OerlinghausenDepartment of Psychiatry, Free University of BerlinSearch for other works by this author on:
-
337 - 340: Discussion of Symposium, and Proposals for Further WorkByT. L. SourkesT. L. SourkesDepartments of Psychiatry and Biochemistry, Faculty of Medicine, McGill University, Montreal, Que., CanadaSearch for other works by this author on:
